BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 12237234)

  • 41. Familial neurofibromatosis 1 microdeletions: cosegregation with distinct facial phenotype and early onset of cutaneous neurofibromata.
    Leppig KA; Kaplan P; Viskochil D; Weaver M; Ortenberg J; Stephens K
    Am J Med Genet; 1997 Dec; 73(2):197-204. PubMed ID: 9409873
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genetic and cellular defects contributing to benign tumor formation in neurofibromatosis type 1.
    Rutkowski JL; Wu K; Gutmann DH; Boyer PJ; Legius E
    Hum Mol Genet; 2000 Apr; 9(7):1059-66. PubMed ID: 10767330
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cell culture studies on neurofibromatosis (von Recklinghausen). V. Monosomy 22 and other chromosomal anomalies in cultures from peripheral neurofibromas.
    Krone W; Högemann I
    Hum Genet; 1986 Dec; 74(4):453-5. PubMed ID: 3098672
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative genomic hybridization analysis of genomic alterations in benign, atypical and anaplastic meningiomas.
    Arslantas A; Artan S; Oner U; Durmaz R; Müslümanoğlu H; Atasoy MA; Başaran N; Tel E
    Acta Neurol Belg; 2002 Jun; 102(2):53-62. PubMed ID: 12161900
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative genomic hybridization detects frequent overrepresentation of chromosomal material from 3q26, 8q24, and 20q13 in human ovarian carcinomas.
    Sonoda G; Palazzo J; du Manoir S; Godwin AK; Feder M; Yakushiji M; Testa JR
    Genes Chromosomes Cancer; 1997 Dec; 20(4):320-8. PubMed ID: 9408747
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Somatic loss of wild type NF1 allele in neurofibromas: Comparison of NF1 microdeletion and non-microdeletion patients.
    De Raedt T; Maertens O; Chmara M; Brems H; Heyns I; Sciot R; Majounie E; Upadhyaya M; De Schepper S; Speleman F; Messiaen L; Vermeesch JR; Legius E
    Genes Chromosomes Cancer; 2006 Oct; 45(10):893-904. PubMed ID: 16830335
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Culture of cytogenetically abnormal schwann cells from benign and malignant NF1 tumors.
    Wallace MR; Rasmussen SA; Lim IT; Gray BA; Zori RT; Muir D
    Genes Chromosomes Cancer; 2000 Feb; 27(2):117-23. PubMed ID: 10612798
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular profiling of malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1, based on large-scale real-time RT-PCR.
    Lévy P; Vidaud D; Leroy K; Laurendeau I; Wechsler J; Bolasco G; Parfait B; Wolkenstein P; Vidaud M; Bièche I
    Mol Cancer; 2004 Jul; 3():20. PubMed ID: 15255999
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mitotic recombination effects homozygosity for NF1 germline mutations in neurofibromas.
    Serra E; Rosenbaum T; Nadal M; Winner U; Ars E; Estivill X; Lázaro C
    Nat Genet; 2001 Jul; 28(3):294-6. PubMed ID: 11431704
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rb and TP53 pathway alterations in sporadic and NF1-related malignant peripheral nerve sheath tumors.
    Birindelli S; Perrone F; Oggionni M; Lavarino C; Pasini B; Vergani B; Ranzani GN; Pierotti MA; Pilotti S
    Lab Invest; 2001 Jun; 81(6):833-44. PubMed ID: 11406645
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Biallelic inactivation of NF1 in a sporadic plexiform neurofibroma.
    Beert E; Brems H; Renard M; Ferreiro JF; Melotte C; Thoelen R; De Wever I; Sciot R; Legius E; Debiec-Rychter M
    Genes Chromosomes Cancer; 2012 Sep; 51(9):852-7. PubMed ID: 22585738
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of noncoding RNA ANRIL in genesis of plexiform neurofibromas in neurofibromatosis type 1.
    Pasmant E; Sabbagh A; Masliah-Planchon J; Ortonne N; Laurendeau I; Melin L; Ferkal S; Hernandez L; Leroy K; Valeyrie-Allanore L; Parfait B; Vidaud D; Bièche I; Lantieri L; Wolkenstein P; Vidaud M;
    J Natl Cancer Inst; 2011 Nov; 103(22):1713-22. PubMed ID: 22034633
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Computer-assisted cytogenetic analysis of 51 malignant peripheral-nerve-sheath tumors: sporadic vs. neurofibromatosis-type-1-associated malignant schwannomas.
    Plaat BE; Molenaar WM; Mastik MF; Hoekstra HJ; te Meerman GJ; van den Berg E
    Int J Cancer; 1999 Oct; 83(2):171-8. PubMed ID: 10471523
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Formation of a minichromosome by excision of the proximal region of 17q in a patient with von Recklinghausen neurofibromatosis.
    Andersen LB; Tommerup N; Koch J
    Cytogenet Cell Genet; 1990; 53(4):206-10. PubMed ID: 2119939
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression analysis of genes lying in the NF1 microdeletion interval points to four candidate modifiers for neurofibroma formation.
    Bartelt-Kirbach B; Wuepping M; Dodrimont-Lattke M; Kaufmann D
    Neurogenetics; 2009 Feb; 10(1):79-85. PubMed ID: 18850118
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The detection of contiguous gene deletions at the neurofibromatosis 1 locus with fluorescence in situ hybridization.
    Leppig KA; Viskochil D; Neil S; Rubenstein A; Johnson VP; Zhu XL; Brothman AR; Stephens K
    Cytogenet Cell Genet; 1996; 72(1):95-8. PubMed ID: 8565646
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Neurofibromatosis type 1 (von Recklinghausen's disease or peripheral neurofibromatosis): from phenotype to gene].
    Sabol Z; Kipke-Sabol L
    Lijec Vjesn; 2005; 127(11-12):303-11. PubMed ID: 16583938
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genetic alterations in a malignant schwannoma from a patient with neurofibromatosis (NF1).
    Lothe RA; Saeter G; Danielsen HE; Stenwig AE; Høyheim B; O'Connell P; Børresen AL
    Pathol Res Pract; 1993 May; 189(4):465-71; discussion 471-4. PubMed ID: 8351250
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Analysis of intratumor heterogeneity in Neurofibromatosis type 1 plexiform neurofibromas and neurofibromas with atypical features: Correlating histological and genomic findings.
    Carrió M; Gel B; Terribas E; Zucchiatti AC; Moliné T; Rosas I; Teulé Á; Ramón Y Cajal S; López-Gutiérrez JC; Blanco I; Castellanos E; Lázaro C; Stemmer-Rachamimov A; Romagosa C; Serra E
    Hum Mutat; 2018 Aug; 39(8):1112-1125. PubMed ID: 29774626
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Complete physical map and gene content of the human NF1 tumor suppressor region in human and mouse.
    Jenne DE; Tinschert S; Dorschner MO; Hameister H; Stephens K; Kehrer-Sawatzki H
    Genes Chromosomes Cancer; 2003 Jun; 37(2):111-20. PubMed ID: 12696059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.